These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 3012316)

  • 1. [Effects of DBcAMP on galactosamine-induced acute liver failure].
    Kakisaka A; Kasai S; Sawa M
    Nihon Geka Gakkai Zasshi; 1986 May; 87(5):581. PubMed ID: 3012316
    [No Abstract]   [Full Text] [Related]  

  • 2. [Protective effects of DBcAMP on acute liver failure induced by D-galactosamine in rats].
    Kakisaka A; Kasai S; Mito M
    Nihon Geka Gakkai Zasshi; 1989 Mar; 90(3):396-403. PubMed ID: 2549363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of viable isolated hepatocytes or hepatocyte fractions on survival rate following galactosamine-induced acute liver failure.
    ten Berg RG; Ernst P; van Maldegem-Dronkers C; Marquet R; Westbroek DL
    Eur Surg Res; 1985; 17(2):109-18. PubMed ID: 3884339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacies of whole blood and plasma cross circulation on galactosamine induced hepatic failure rats.
    Okabe K; Ouchi K; Koyama K; Sato T
    Trans Am Soc Artif Intern Organs; 1984; 30():395-8. PubMed ID: 6533913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphological characteristics of D-galactosamine hepatitis].
    Popov A; Klouchek-Popova E; Stoilova M
    Eksp Med Morfol; 1983; 22(2):74-80. PubMed ID: 6667658
    [No Abstract]   [Full Text] [Related]  

  • 6. [Favorable action of preliminary fasting on changes in liver plasma membrane enzymes due to the use of D-galactosamine].
    Adzharov D; Dimov S; Savov G; Naĭdenova E; Petrova S
    Eksp Med Morfol; 1987; 26(2):20-3. PubMed ID: 3608898
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effects of preliminary fasting on the development of D-galactosamine-induced acute lesion of the liver in rats].
    Adzharov D; Donchev N; Kerimova M; Naĭdenova E; Borov B
    Biull Eksp Biol Med; 1989 Jan; 107(1):33-6. PubMed ID: 2914170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of disulfiram on function of the liver of rats with galactosamine-induced hepatitis.
    Mach T
    Pol J Pharmacol Pharm; 1986; 38(3):235-41. PubMed ID: 3095801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of activated polymorphonuclear leukocytes in galactosamine-induced hepatic injury in rats.
    Hino Y; Kumashiro R; Tanaka M; Shimada M; Harada M; Yoshitake M; Sata M; Tanikawa K
    Gastroenterol Jpn; 1991 Aug; 26(4):545. PubMed ID: 1655555
    [No Abstract]   [Full Text] [Related]  

  • 10. Experimental hepatitis induced by D-galactosamine.
    Keppler D; Lesch R; Reutter W; Decker K
    Exp Mol Pathol; 1968 Oct; 9(2):279-90. PubMed ID: 4952077
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzymatic defence against oxygen toxicity in D-galactosamine-induced hepatitis in rats.
    D'Souza NB; Kulkarni AB; Baxi AJ; Nadkarni GD
    Indian J Gastroenterol; 1985 Apr; 4(2):87-8. PubMed ID: 3845914
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective effects of fibronectin in galactosamine-induced liver failure in rats.
    Moriyama T; Aoyama H; Ohnishi S; Imawari M
    Hepatology; 1986; 6(6):1334-9. PubMed ID: 3793010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Experimental study on the role of endotoxin in the mechanism of galactosamine-induced liver injury].
    Tsubomizu Y; Kobayashi A; Sugata F
    Nihon Shokakibyo Gakkai Zasshi; 1986 Sep; 83(9):2035-42. PubMed ID: 3795572
    [No Abstract]   [Full Text] [Related]  

  • 14. Protective effects of Alpha-tocopherol on the hepatotoxicity of D-galactosamine.
    Mihas AA; Doos W; Gibson RG; Hirschowitz BI
    Ala J Med Sci; 1976 Oct; 13(4):384-7. PubMed ID: 984338
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of pretreatment of rats with uracil on liver injuries induced by D-galactosamine and allyl alcohol.
    Kitajima S; Ogawa N; Ariyoshi T
    Res Commun Mol Pathol Pharmacol; 1994 Jul; 85(1):14-20. PubMed ID: 7953190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Protective and curative effects of diethyldithiocarbamate on galactosamine hepatitis in the rat (author's transl)].
    Homann J; Gerhardt H; Hopf F
    Arzneimittelforschung; 1980; 30(4):645-7. PubMed ID: 6249330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hypovolaemia and haemoconcentration in rats with galactosamine-induced hepatitis].
    Liehr H; Grün M; Richter E; Thiel H; Krauss H; Brachtel D
    Klin Wochenschr; 1972 May; 50(10):524-6. PubMed ID: 5042538
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathogenic significance of endotoxemia in acute experimental liver failure].
    Fang YQ; Hou C
    Zhonghua Yi Xue Za Zhi; 1988 Mar; 68(3):147-9. PubMed ID: 3136893
    [No Abstract]   [Full Text] [Related]  

  • 19. [Experimental research on the hepatoprotective activity of drug combinations].
    Drenska D; Ovcharov R; Klouchek E; Popov A
    Eksp Med Morfol; 1985; 24(1):54-9. PubMed ID: 4029071
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of regenerating liver cytosol on drug-induced hepatic failure.
    Ohkawa M; Hayashi H; Chaudry IH; Clemens MG; Baue AE
    Surgery; 1985 Apr; 97(4):455-62. PubMed ID: 3983821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.